Neurable company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Series A - IV | Alive

Total Raised


Last Raised

$1M | 1 yr ago

About Neurable

Neurable develops VR technology that can be controlled by brain activity.

Neurable Headquarter Location

45 Bromfield St Suite 7

Boston, Massachusetts, 02108,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Neurable

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Neurable in 1 CB Insights research brief, most recently on Mar 30, 2022.

Expert Collections containing Neurable

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Neurable is included in 1 Expert Collection, including AR/VR.



1,368 items

Neurable Patents

Neurable has filed 5 patents.

The 3 most popular patent topics include:

  • Assistive technology
  • Neuroscience
  • Electroencephalography
patents chart

Application Date

Grant Date


Related Topics




Electroencephalography, Neurophysiology, Assistive technology, Neuroscience, Neurotechnology


Application Date


Grant Date



Related Topics

Electroencephalography, Neurophysiology, Assistive technology, Neuroscience, Neurotechnology



Latest Neurable News

Global Brain Computer Interface Market to Top $1.6B by 2028

Sep 2, 2021

Global Brain Computer Interface Market to Top $1.6B by 2028 Growth partly expected from collaborations among various research institutes to develop bran disease diagnostics. Globe Newswire09.02.21 According to Coherent Market Insights , the global brain computer interface market is estimated to be valued at $773.0 million in 2021 and is expected to exhibit a CAGR of 11.4 percent over the forecast period (2021-2028). The increasing number of product approvals, product launches, and collaborations and partnership strategies adopted by key players are the major factors, which are expected to drive the market growth over the forecast period. For instance, in April 2018, LivaNova received the CE Mark for its Vagus Nerve Stimulation Therapy System consisting of SenTiva generator and next-generation programming system for epileptic patients. Moreover, in 2018, Rapid Medical, a company focused on the development of next generation neurovascular devices, received European CE Mark approval for its TIGERTRIEVER. The TIGERTRIEVER is the first-ever adjustable, fully visible clot retriever, is designed to treat ischemic stroke patients. Furthermore, increasing collaborations among various research institutes for development of novel diagnosis techniques for brain disease is expected to drive the growth of market in the near future. In 2017, Singapore-based National Neuroscience Institute and Nanyang Technological University, Singapore (NTU Singapore) entered into a collaboration for development of novel and innovative technologies to better diagnose and treat patients with neurological conditions such as Parkinson’s disease and brain injuries. The global brain computer interface market is expected to exhibit a CAGR of 11.4 percent over the forecast period. Owing major market player is focusing on inorganic growth strategies such as collaboration to strengthen its position in the market. For instance, in January 2019, Neurable, a software company announced that it will collaborate with Trimble, a software and services technology company. The collaboration focuses on bringing the brain-computer interface (BCI) technology to innovative solutions in the transportation and architecture, engineering and construction (AEC) industries. Key players operating in the global brain computer interface market include Neuralink Corporation, Neurable, Emotiv Inc., BitBrain, Alpha Omega, Blackrock Microsystems LLC, Femtonics Ltd., NeuroNexus, Opto Circuits (India) Limited, BIOTRONIK, Plexon Inc., Noldus Information Technology, NextMind, Nectome, and Paradromics. Related Breaking News PR Newswire 09.02.21 Business Wire 09.02.21 GlobalData 09.02.21 PR Newswire 09.02.21 Baxter International 09.02.21 Business Wire 09.01.21 Business Wire 09.01.21 PR Newswire 09.01.21 Globe Newswire 09.01.21 PR Newswire 09.01.21 GlobalData 09.01.21 Business Wire 09.01.21 Philips 09.01.21 Tissium 09.01.21

Neurable Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Neurable Rank

You May Also Like

Synchron Logo

Synchron is a medical device company focused on the development of minimally invasive neuromodulation technology solutions. Synchron is developing an endovascular neural interface, the StentrodeTM.

Paradromics Logo

Paradromics develops brain-machine interfaces that will increase the data transmission rate between brains and computers. This will enable better treatment options for neurodegenerative diseases and advanced neuroprosthetic limbs for those suffering from amputation or spinal cord injuries.

Neuralink Logo

Neuralink develops ultra high bandwidth brain-machine interfaces to connect humans and computers.

Kernel Logo

Kernel is a human intelligence company developing neuroprosthesis to mimic, repair, and improve cognition. Kernel's Neuroscience as a Service (NaaS) gives on-demand access to its brain recording technology.

Valencell Logo

Valencell develops performance biometric sensor technology and licenses this patent-protected technology to consumer electronics manufacturers, mobile device and accessory makers, sports and fitness brands and gaming companies for integration into their products. Valencell's PerformTek biometric sensor technology employs active signal characterization to actively characterize biophysical signals for removing physical noise and extracting highly accurate biometric information.


Naolu Technology (also known as BrainUp) focuses on the application of human brain cutting-edge technologies such as brain-computer interface, early screening of brain health, and artificial intelligence of brain-like decision computing. The firm specializes in-depth in EEG sleep-aid, brain fMRI image analysis and industry real-time brain diagnosis solutions.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.